v3.26.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Assets    
Cash and cash equivalents $ 393 $ 420
Accounts receivable, net of allowance for credit losses of $27 and $25 as of March 31, 2026 and December 31, 2025, respectively 1,587 1,408
Inventories 225 189
Prepaid expenses and other current assets 361 361
Total current assets 2,566 2,378
Property, plant and equipment, net 2,189 2,203
Operating lease right-of-use assets 691 657
Goodwill 9,120 8,945
Intangible assets, net 1,717 1,636
Investments in equity method investees 134 136
Other assets 256 270
Total assets 16,673 16,225
Current liabilities:    
Accounts payable and accrued expenses 1,500 1,600
Current portion of long-term debt 503 504
Current portion of long-term operating lease liabilities 174 174
Total current liabilities 2,177 2,278
Long-term debt 5,155 5,167
Long-term operating lease liabilities 574 537
Other liabilities 1,022 957
Commitments and contingencies
Redeemable noncontrolling interest 79 80
Quest Diagnostics stockholders’ equity:    
Common stock, par value $0.01 per share; 600 shares authorized as of both March 31, 2026 and December 31, 2025; 162 shares issued as of both March 31, 2026 and December 31, 2025 2 2
Additional paid-in capital 2,347 2,381
Retained earnings 10,151 9,994
Accumulated other comprehensive loss (43) (27)
Treasury stock, at cost; 51 shares and 52 shares as of March 31, 2026 and December 31, 2025, respectively (5,091) (5,180)
Total Quest Diagnostics stockholders’ equity 7,366 7,170
Noncontrolling interests 300 36
Total stockholders’ equity 7,666 7,206
Total liabilities and stockholders’ equity $ 16,673 $ 16,225